Clinical Trials Logo

Cardiovascular Complication clinical trials

View clinical trials related to Cardiovascular Complication.

Filter by:

NCT ID: NCT05243446 Recruiting - Clinical trials for Cardiovascular Complication

Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

CELART
Start date: September 2015
Phase:
Study type: Observational

The influence of Losartan to cardiovascular and renal outcomes in patients after renal transplatation.

NCT ID: NCT05208957 Not yet recruiting - Clinical trials for Perioperative Complication

Cardiovascular Outcomes and Mortality in Vascular Surgical Patients

Start date: June 2022
Phase:
Study type: Observational [Patient Registry]

This is a registry-based study of elective vascular surgical patients undergoing intermediate or high-risk vascular surgical interventions at Groote Schuur hospital, a tertiary academic center, over a 12 month period.

NCT ID: NCT05130489 Completed - Clinical trials for Cardiovascular Diseases

CAR T Cell Therapy Related Cardiovascular Outcomes

CARTCO
Start date: January 18, 2021
Phase:
Study type: Observational

This will be a cohort study of all patients receiving Cluster of Differentiation 19 (CD19)-specific CAR T cell therapy for relapsed/refractory B cell haematological malignancies. Patients will receive cardiac assessment and have serum cardiac biomarkers, ECG, transthoracic echocardiogram and cardiac magnetic resonance imaging performed at baseline prior to CAR T cell therapy, 7 days post CAR T cell infusion, and 3 months post CAR T cell infusion. Abnormalities in these cardiac investigations will be used to demonstrate cardiac injury and identify which patients are most at risk of developing cardiac injury related to CAR T cell therapy.

NCT ID: NCT05116280 Completed - Stroke Clinical Trials

MACE and PE in Elective Primary TKA & THA

Start date: January 1, 2018
Phase:
Study type: Observational

This study ought to identify the occurence of the major adverse cardiovascular events (MACE) and the pumonary emoblism (PE) in patients undergoing elective primary THA & TKA

NCT ID: NCT05084846 Recruiting - Influenza Clinical Trials

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection

FluHeart
Start date: January 1, 2022
Phase:
Study type: Observational

"Influenza and the Heart: An investigation into the acute and lasting cardiac effects of influenza infection" the investigators aim to assess the mechanisms for cardiovascular disease in patients suffering an acute influenza infection. The project will be carried out by creating a prospective clinical cohort study of consecutive patients hospitalized at Herlev & Gentofte University Hospital with a laboratory confirmed influenza.

NCT ID: NCT05077748 Recruiting - Clinical trials for Obstructive Sleep Apnea

An 18-year Follow-up Study on OSA in a Population-based Cohort

Start date: October 20, 2021
Phase:
Study type: Observational

Our research team has established a polysomnography (PSG) quantified population-based paediatric sleep cohort in 2003 for a childhood OSA prevalence study. Subjects were recruited from 13 randomly selected primary schools. All subjects from this original cohort will be invited to join this 18-year follow-up study to repeat the following data collection: questionnaires, anthropometric measurement, sleep study, 24-hour ambulatory blood pressure (ABP) measurement, echocardiography and neurocognitive assessment.

NCT ID: NCT04980716 Recruiting - Clinical trials for Non-small Cell Lung Cancer

Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients

Start date: June 1, 2021
Phase: Phase 3
Study type: Interventional

This is a prospective, randomized, controlled, multi-center phase III clinical trial that intends to evaluate the role of early cardiovascular intervention based on impedance cardiography in patients with locally advanced non-small cell lung cancer receiving radical radiochemotherapy±immunotherapy.

NCT ID: NCT04802122 Completed - Intubation Clinical Trials

Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects.

Start date: May 24, 2021
Phase: Phase 4
Study type: Interventional

Airway management is of outmost importance in the perioperative period. One of the main questions while making a plan for airway management is whether spontaneous ventilation should be maintained or not. Induction of anesthesia with Sevoflurane is a conventional technique that preserves spontaneous ventilation. It is used especially in non-collaborating patients or when other pharmaceutical agents or sophisticated airway management equipment is out of reach. Inhalational induction of anesthesia with Sevoflurane is well studied. However, there are few studies investigating the effects of Sevoflurane on induction and intubating conditions, on cardiopulmonary physiology, on emergence conditions, when it is used as one and only agent to achieve induction of anesthesia, intubation and maintenance of anesthesia in adult patients. There is also no consensus on the appropriate duration of the inhalational induction or other criteria to guarantee successful intubation conditions, since most studies investigate Sevoflurane administration until induction of anesthesia and not until intubation. From all the above, it appears that there are a few gaps in the management of patients who are to be intubated with Sevoflurane only, without the use of any other anesthetic agents.

NCT ID: NCT04753307 Recruiting - Inflammation Clinical Trials

Perioperative Inflammatory Response Assessment in High-risk Patients Undergoing Noncardiac Surgery

INSIGHT
Start date: January 19, 2021
Phase:
Study type: Observational

Postoperative cardiovascular complications are common after noncardiac surgery. The association between perioperative inflammation and the occurrence of cardiovascular complications after surgery is still unknown. Therefore, we will evaluate as our primary aim the association between patients with increased postoperative inflammation, assessed with C-reactive protein measurements, and the occurrence of major cardiovascular complications after noncardiac surgery. We will further evaluate the influence of perioperative inflammation on the occurrence of postoperative acute kidney injury. We will also evaluate the association between inflammation and the influence on Days-At-Home within 30 days. Furthermore, we will evaluate the association between increased inflammatory biomarkers and postoperative N-terminal pro brain natriuretic peptide (NT-proBNP) concentration.

NCT ID: NCT04696081 Recruiting - Cancer Clinical Trials

Atrial Fibrillation in Active Cancer Patients

AFIB-CANCER
Start date: September 1, 2021
Phase:
Study type: Observational [Patient Registry]

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients with an active cancer and experiencing atrial fibrillation to study major cardiovascular events occurrence during a 1 year follow-up.